Evolution of a Paradigm Switch in Diagnosis and Treatment of HPV-Driven Head and Neck Cancer—Striking the Balance Between Toxicity and Cure
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2021.753387
Abstract: More than a decade after the discovery of p16 immunohistochemistry (IHC) as a surrogate for human papilloma virus (HPV)-driven head and neck squamous cell carcinoma (HNSCC), p16-IHC has become a routinely evaluated biomarker to stratify… read more here.
Keywords: hpv; toxicity; head neck; treatment ... See more keywords
Advanced Nanomedicine for High-Risk HPV-Driven Head and Neck Cancer
Sign Up to like & getrecommendations! Published in 2022 at "Viruses"
DOI: 10.3390/v14122824
Abstract: The incidence of high-risk Human Papillomavirus (HR-HPV)-driven head and neck squamous cell carcinoma (HNSCC) is on the rise globally. HR-HPV-driven HNSCC displays molecular and clinical characteristics distinct from HPV-uninvolved cases. Therapeutic strategies for HR-HPV-driven HNSCC… read more here.
Keywords: nanotechnology; head neck; high risk; driven head ... See more keywords